Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arthritis & Rheumatism

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.10467PMID 12209504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

  2002cited by this paper
• Pathogenesis of rheumatoid arthritis. Role of B lymphocytes.

  2001cited by this paper
• T Cell Activation in Rheumatoid Synovium Is B Cell Dependent1

  2001cited by this paper
• Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.

  2001cited by this paper
• Cytokine pathways and joint inflammation in rheumatoid arthritis.

  2001cited by this paper
• B cells in rheumatoid arthritis

  2000cited by this paper
• Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

  2000cited by this paper
• Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma.

  1998cited by this paper
• Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

  1996cited by this paper
• Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

  1994cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper

• Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies

  2025cites this paper
• Mitochondrial functioning in Rheumatoid arthritis modulated by estrogen: Evidence-based insight into the sex-based influence on mitochondria and disease.

  2024cites this paper
• Characteristics of the IgM Repertoires in the Peripheral Blood of Early Rheumatoid Arthritis Patients.

  2024cites this paper
• B-cell depletion in autoimmune diseases

  2024cites this paper
• Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism

  2024cites this paper
• Synovial Tissue Lymphoid Aggregates Are Associated With Response To Rituximab Therapy In Rheumatoid Arthritis Patients

  2022cites this paper
• Immuno-modulating theranostic gold nanocages for the treatment of rheumatoid arthritis in vivo

  2022cites this paper
• Dose-Dependent Efficacy of Umbelliferone and Gelatin-Coated ZnO/ZnS Core-Shell Nanoparticles: A Novel Arthritis Agent for Severe Knee Arthritis

  2022influential citation
• Epitope Mapping of the Anti-CD20 Monoclonal Antibodies (C20Mab-11 and 2H7) Using HisMAP Method

  2022cites this paper
• Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans

  2022cites this paper
• Engineering Mucic Acid Loaded Polyethylenimine@GoldNanoparticles for Improving the Treatment of Rheumatoid Arthritis

  2021cites this paper
• Emerging Biological and Molecular Therapies in Autoimmune Disease

  2020cites this paper
• β-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice

  2019cites this paper
• Novel Autoantibodies in RA and Involvement of SUMO Pathway in the Intrinsic Activation of RASF

  2019cites this paper
• Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic Mechanisms

  2018cites this paper
• Predictive biomarkers in rheumatoid arthritis

  2018influential citation
• A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection.

  2017cites this paper
• RhoB blockade selectively inhibits autoantibody production in autoimmune models of rheumatoid arthritis and lupus

  2017cites this paper
• Chapter 64 – Cell-Targeted Biologics and Emerging Targets: Rituximab, Abatacept, and Other Biologics

  2017cites this paper
• Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis.

  2017cites this paper
• Arthritisand Bone Marrow in Rheumatoid Interaction between Synovial Inflammatory

  2017cites this paper
• Pathogenetic insights from the treatment of rheumatoid arthritis.

  2017cites this paper
• The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab.

  2017cites this paper
• Lineage-specific and single cell chromatin accessibility charts human hematopoiesis and leukemia evolution

  2016cites this paper
• Homeostatic regulation of T cell trafficking by a B cell derived peptide is impaired in autoimmune and chronic inflammatory disease

  2015cites this paper
• Pathogene Zellen der rheumatischen Entzündung als Ziele moderner Therapien

  2015cites this paper
• Tespa1 is associated with susceptibility but not severity of rheumatoid arthritis in the Zhejiang Han population in China

  2015cites this paper
• A systematic review of the use of rituximab as induction therapy in renal transplantation.

  2015cites this paper
• A new rescue regimen with plasma exchange and rituximab in high‐risk membranous glomerulonephritis

  2015cites this paper
• Biotherapies targeting T and B cells: from immune suppression to immune tolerance.

  2015cites this paper
• Identification, quantification et caractérisation de l'ADN mitochondrial au cours de la polyarthrite rhumatoïde

  2015cites this paper
• [Pathogenic cells of rheumatic inflammation as the target of modern therapies].

  2015cites this paper
• Mechanisms of autoimmunity in human diseases: a critical review of current dogma

  2014cites this paper
• Skeleton, Inflammatory Diseases of

  2014cites this paper
• etude de sa source cellulaire

  2014cites this paper
• ArtritisInmunopatología de la artritis reumatoide

  2014cites this paper
• Personalized Healthcare in Autoimmune Diseases

  2014cites this paper
• B-Cell Targeted Therapies in Rheumatoid Arthritis

  2014cites this paper
• Imaging B lymphocytes in autoimmune inflammatory diseases.

  2014cites this paper
• Treatment of Autoimmune Disease: Biological and Molecular Therapies

  2014cites this paper
• Apoptotic B cells: their interactions with macrophages and modulation by rituximab

  2014cites this paper
• Characterization of peripheral blood B cell subpopulations in Rheumatoid Arthritis

  2014cites this paper
• Immunopathologie de la polyarthrite rhumatoïde

  2014cites this paper
• L’ADN mitochondrial, nouvel acteur de l’immunité innée, est-il impliqué dans la polyarthrite rhumatoïde ? Détection, quantification et étude de sa source cellulaire

  2014cites this paper
• A Systematic Review of the Use of Rituximab for Desensitization in Renal Transplantation

  2014cites this paper
• The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

  2013cites this paper
• 64 – Cell-Targeted Biologics and Targets: Rituximab, Abatacept, and Other Biologics

  2013cites this paper
• 11 cases ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of Efficiency of curative and prophylactic treatment with rituximab in

  2013cites this paper
• Scientific Basis of Botanical Medicine as Alternative Remedies for Rheumatoid Arthritis

  2013cites this paper
• The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.

  2013cites this paper
• Rituximab for the treatment of rheumatoid arthritis: an update

  2013cites this paper
• Rituximab treatment for adult purpura nephritis with nephrotic syndrome.

  2013cites this paper
• Association of the FCGR3A-158F/V Gene Polymorphism with the Response to Rituximab Treatment in Spanish Systemic Autoimmune Disease Patients

  2012cites this paper
• Anti citrullinated protein antibodies and mechanism of action of common disease modifying drugs--insights in pathomechanisms of autoimmunity.

  2012cites this paper
• RESEARCH ARTICLE 99m Tc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients

  2012cites this paper
• The Role of Rituximab in the Therapy of Mixed Cryoglobulinemia

  2012cites this paper
• B Cell-Targeted Therapy for Rheumatoid Arthritis

  2012cites this paper
• Association Between −174 Interleukin-6 Gene Polymorphism and Biological Response to Rituximab in Several Systemic Autoimmune Diseases

  2012cites this paper
• The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis.

  2012cites this paper
• ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis

  2012cites this paper
• Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients.

  2012cites this paper
• Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model

  2012cites this paper
• Rituximab in idiopathic membranous nephropathy.

  2012cites this paper
• New drug targets in atopic dermatitis.

  2012cites this paper
• The role of CD4 T helper cells and sialylated antigen-specific IgG antibodies in rheumatic autoimmune diseases

  2011cites this paper
• Bioinformatic studies of the disposition pathways and targets of synthetic drugs and herbal medicines

  2011cites this paper
• The Roles of B Cells and Their Interactions with Fibroblast-Like Synoviocytes in the Pathogenesis of Rheumatoid Arthritis

  2011cites this paper
• Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

  2011cites this paper
• Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

  2011cites this paper
• Arthritis in space and time – To boldly go!

  2011cites this paper
• Caractérisation de l'interaction de l'auto-antigène ADN topoisomérase I avec les fibroblastes dans la sclérose systémique

  2011cites this paper
• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis.

  2011cites this paper
• The role of TH17 cells in a model of rheumatoid arthritis

  2011cites this paper
• The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction

  2011cites this paper
• New insight in the mechanism of action of rituximab: the interferon signature towards personalized medicine.

  2011cites this paper
• [Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis].

  2011cites this paper
• 99mTc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients

  2011cites this paper
• Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.

  2011cites this paper
• Targeting Chemokines and Angiogenesis in Rheumatoid Arthritis

  2011cites this paper
• Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells

  2010cites this paper
• the Generation of T Follicular Helper Cells a Murine Model of Arthritis via Effects on Abatacept Limits Breach of Self-Tolerance in

  2010cites this paper
• Chemokines and chemokine receptors in arthritis.

  2010cites this paper
• B‐cell targeted therapies in human autoimmune diseases: an updated perspective

  2010cites this paper
• Quantitative MR in multi‐center clinical trials

  2010cites this paper
• Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

  2010cites this paper
• Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.

  2010cites this paper
• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

  2010cites this paper
• Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab

  2010cites this paper
• In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice

  2010cites this paper
• Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation

  2010cites this paper
• The pathogenic role of rheumatoid factor in rheumatoid arthritis

  2010cites this paper
• Long term treatment of rheumatoid arthritis with rituximab.

  2009cites this paper
• BAFF from bone marrow-derived mesenchymal stromal cells of rheumatoid arthritis patients improves their B-cell viability-supporting properties.

  2009cites this paper
• Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report

  2009cites this paper
• Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates

  2009cites this paper
• Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis

  2009cites this paper
• Iguratimod (T-614): A novel disease modifying anti-rheumatic drug

  2009cites this paper
• Long‐Term Effects of Rituximab in Rheumatoid Arthritis

  2009cites this paper
• Chemokines and chemokine receptors

  2009cites this paper
• Procédés pour traiter la sclérose en plaques progressive

  2009cites this paper